All trading involves risk. Ensure you understand those risks before trading.
All trading involves risk. Ensure you understand those risks before trading.

Arm stock: Wall Street sees upside potential from new strategy

Article By: ,  Former Market Analyst

Key takeaways

  • Wave of brokers have initiated coverage on Arm after the quiet period following its IPO expired
  • Initial coverage was muted, but average target price now implies around 11% potential upside as more optimistic views start to feed through
  • Arm still trades at a big premium, but most analysts believe the strength of its core business and new strategy justifies this and can deliver growth
  • Arm shares have flirted with its IPO price since listing but has remained in positive territory
  • New ratings should support share price, but gains could still be limited in the near-term

 

Arm stock faces Wall Street judgement

This could be a big week for British semiconductor designer Arm, which completed its blockbuster IPO last month. Around 30 major banks are able to publish their view on the company from this week after the quiet period following Arm’s listing expired, and many have wasted no time in initiating coverage this morning.

That means we are getting fresh insight into exactly what analysts at major banks think about Arm’s business, prospects and, most importantly, valuation. The initial view from the few big banks that were not beholden to the quiet period was muted, with the consensus being that there isn’t much upside potential from current levels.

However, we have already seen that some have a rosier view. Here are the latest ratings and price targets for Arm set on Monday morning:

  • Citigroup: Buy rating and a $65 price target
  • Barclays: Overweight rating and $65 price target
  • BNPP Exane: Outperform and $65 price target
  • Jefferies: Buy rating and $64 price target
  • Cowen & Co: Outperform rating and a $63 price target
  • Goldman Sachs: Buy rating with a $62 price target
  • Mizuho: Buy and $62 price target
  • BMO: Market Perform rating and $60 price target
  • Deutsche Bank: Buy rating and $60 price target
  • HSBC: Hold rating and a $57 price target

All-in-all, the average target price on Arm now sits at $60, according to a Bloomberg-compiled consensus of 14 brokers. That is about 11% higher than where Arm shares ended play on Friday. For more context, the range now spans from as low as $46 to as high as $65.

 

What will this mean for Arm stock?

Arm shares closed at just above $54 on Friday, only marginally above its $51 IPO price. That means Arm is still trading at over 100x earnings based on its most recent annual results, giving it a huge premium over its rivals and the broader market.

Arm convinced Wall Street during its IPO roadshow that it should earn a premium because it has  a new strategy that will see it supply more comprehensive and advanced chip designs for hot areas like AI and electric vehicles that can earn higher royalties. However, the valuation remains stretched based on the business today, which is known for having a monopoly supplying generic designs for more basic chips used in consumer electronics such as smartphones.

The brokers that initiated coverage this morning were, broadly speaking, optimistic that Arm can at least maintain if not grow this premium valuation.

Barclays said Arm is well-positioned to grow as more devices become ‘smart’ and said it sees a roadmap for the company to grow EPS to over $3 by 2030. That would be almost six-times as high as the $0.52 delivered in the most recent financial year! Jefferies agreed and said the move to higher-performance chips for datacenters and GPUs will boost royalties over what it earns on supplying CPUs for smartphones. Cowen & Co said Arm is not fully monetizing its market value, which was a point stressed by Arm’s management during the IPO roadshow.

You can read my analysis on Arm and its new strategy in Can Arm Stock Sustain or Grow its Premium Valuation?

 

 

Where next for Arm stock?

It is very early days for Arm stock, so the daily chart does not provide much insight as to where the share price is headed next. Still, it is worth checking in to show how Arm shares have performed since going public. We believe the key levels to watch are the IPO price of $51 and the average target price at $60. In-between, a move above $57 would allow it to break above the peak set since the share price stabilised after its listing. 

The stock is trading up 0.5% in early premarket trade this morning.

 

How to trade Arm stock

You can trade Arm shares with City Index in just four easy steps:

  1. Open a City Index account, or log-in if you’re already a customer.
  2. Search for ‘Arm’ in our award-winning platform
  3. Choose your position and size, and your stop and limit levels
  4. Place the trade

Or you can practice trading risk-free by signing up for our Demo Trading Account.

 

 

 

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

City Index is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.

© City Index 2024